|

VA Clinical Trials

2 actively recruiting trials

Also known as: Venetoclax+Azacitidine

Pipeline

Phase 2: 1Phase 3: 1

Top Sponsors

  • The First Affiliated Hospital of Soochow University1
  • Nanfang Hospital, Southern Medical University1

Indications

  • Cancer2
  • Newly Diagnosed Acute Myeloid Leukemia With High Risk1
  • Newly Diagnosed1
  • Acute Myeloid Leukemia, Adult1

Other2 trials

Comparison of VA (Venetoclax, Azacitidine), VACl (VA, Cladribine), VACh (VA, Chidamide), and Alternating VACl/VACh in Newly Diagnosed Acute Myeloid Leukemia
Phase 2
HVA vs IA/DA or VA in the Treatment of ND HR-AML
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.